CLINICAL_TRIALS
trial_result
· 2018-11-14
Clinical Trial Update: Safety and Efficacy of Cariprazine in Schizophrenia [Phase 3]
Summary
Phase 3 trial update assessing safety and efficacy of cariprazine in schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2018-11-14